Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-22-005357
Filing Date
2022-02-14
Accepted
2022-02-14 17:01:04
Documents
1
Group Members
DAVID C. OTTDRAGSA 76 LLCO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES LIQUID PORTFOLIO SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES PARENT GP LLCV

Document Format Files

Seq Description Document Type Size
1 SC 13GA brhc10033254_sc13ga.htm SC 13G/A 347045
  Complete submission text file 0001140361-22-005357.txt   348930
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

EIN.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Subject) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91923 | Film No.: 22634189
SIC: 2834 Pharmaceutical Preparations